Literature DB >> 8874609

The abuse of dextromethorphan-based cough syrup: a pilot study of the community of Waynesboro, Pennsylvania.

M N Darboe1, G R Keenan, T K Richards.   

Abstract

Drug abuse has been a national social problem in the United States for decades and is often complicated by the emergence of new types of abused drugs or new forms of abuse. In the late 1980s, the community of Waynesboro, Pennsylvania began to detect behavior among its teenagers that suggested a new form of drug abuse and thus a new social problem. The drug was dextromethorphan, used in cough syrup-principally Robitussin DM. The form of abuse is often referred to as "roboing" or "robo-copping." This paper presents the results of the first phase of a comprehensive investigation of this phenomenon in the Waynesboro school district. Data from a survey of school personnel indicate that abuse of cough syrup (Robitussin or other brands) has increased over the years and is increasingly perceived as a problem by the community.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8874609

Source DB:  PubMed          Journal:  Adolescence        ISSN: 0001-8449


  4 in total

1.  Impairments in water maze learning of aged rats that received dextromethorphan repeatedly during adolescent period.

Authors:  Tie Yuan Zhang; Hee Jeong Cho; Seoul Lee; Jong-Ho Lee; Si Ho Choi; Vitaly Ryu; Sang Bae Yoo; Joo Young Lee; Dong Goo Kim; Jeong Won Jahng
Journal:  Psychopharmacology (Berl)       Date:  2006-10-05       Impact factor: 4.530

2.  Personal construction of cough medicine among young substance abusers in Hong Kong.

Authors:  Daniel T L Shek
Journal:  ScientificWorldJournal       Date:  2012-04-19

3.  "Robo-tripping": dextromethorphan abuse and its anesthetic implications.

Authors:  Kelly A Linn; Micah T Long; Paul S Pagel
Journal:  Anesth Pain Med       Date:  2014-11-14

4.  Ovariectomy ameliorates dextromethorphan--induced memory impairment in young female rats.

Authors:  Jeong Won Jahng; Hee Jeong Cho; Jae Goo Kim; Nam Youl Kim; Seoul Lee; Yil Seob Lee
Journal:  J Cell Mol Med       Date:  2006 Jan-Mar       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.